Severe to Profound Hearing Loss

2

Review clinical trials related to Severe to Profound Hearing Loss. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hearing and Structure Preservation Via ECochG

The goal of the study is to determine the benefit of using an ECochG-based corrective action guide during cochlear implant surgery compared to the traditional surgical approach without ECochG surveillance and guidance.

Participants needed: 102
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Advanced Bionics AGUpdated: Jan 6, 2026Locations: 7
Eligibility criteria

Aged 18 years of age or older [+10]

Abnormal cochlear anatomy (including ossification) as identified by pre-operativ... [+10]

Status: Recruiting

Impact of Robotic Cochlear Implantation on Hearing Performance in Noise

The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment. To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year). Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.

Participants needed: 140
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Feb 17, 2025Locations: 1
Eligibility criteria

Adult patient ≥ 18 years old [+3]

Patient who does not speak French [+7]